How does it work?

During the follow-up phase of lung cancer treatment (after surgery/radiotherapy for stage I/II, after chemoradiation with or without adjuvant immunotherapy for stage III, or after oligometastatic treatment or palliative therapy for stage IV), patients are provided with the Luscii app, which allows them to monitor their symptoms at home. Through the app, patients can track their weight and fill out questionnaires about their health. In case of any deviation from their baseline measurements, the CWZ medical service center will contact the patient through a video call to provide further guidance. This way, any deterioration can be detected early, and the care plan can be optimized. Furthermore, the use of Luscii can reduce the need for extra physical checkups that go beyond the regular protocol.

In addition, this program can also support clinicians in making decisions regarding whether a CT-scan is necessary. Instead of relying solely on protocol, clinicians can use the data collected through the app to determine whether a CT-scan is indicated, potentially leading to a decrease in the number of unnecessary scans.

Overall, the use of this program can improve the quality of care for lung cancer patients during their follow-up phase, by enabling them to monitor their symptoms at home and providing early intervention when necessary.